Israel Englander’s Haemonetics HAE Stock Holding History

Israel Englander’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$1.49M	–	6191
2025 Q2	$1.49M	Buy	20,000 +15,000	+300%	+$993K	﹤0.01%	4119
2025 Q1	$318K	Buy	+5,000	New	+$340K	﹤0.01%	5071
2024 Q1	–	Sell	-20,000	Closed	-$1.71M	–	6369
2023 Q4	$1.71M	Buy	+20,000	New	+$1.73M	﹤0.01%	3731
2023 Q1	–	Sell	-15,000	Closed	-$1.18M	–	6559
2022 Q4	$1.18M	Buy	+15,000	New	+$1.21M	﹤0.01%	4001
2021 Q3	–	Sell	-10,000	Closed	-$666K	–	6963
2021 Q2	$666K	Sell	10,000 -20,000	-67%	-$1.42M	﹤0.01%	5041
2021 Q1	$3.33M	Hold	30,000	–	–	﹤0.01%	3028
2020 Q4	$3.56M	Buy	+30,000	New	+$3.23M	﹤0.01%	2770

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's HAE Position: Q2 2026 in Review

Israel Englander increased its Haemonetics (HAE) stake by 5,730% in Q2 2026, buying an estimated $36M and bringing the position to 570,413 shares worth $42.8M. The position accounts for 0.02% of the portfolio, ranked #998.

Israel Englander first reported a position in HAE in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.6M in Q1 2018. 327 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Israel Englander held 570,413 shares of Haemonetics worth $42.8M as of Q2 2026.
Israel Englander bought 560,629 Haemonetics shares in Q2 2026, an estimated $36M.
Haemonetics made up 0.02% of Israel Englander's portfolio in Q2 2026, its #998 holding.
Israel Englander first reported a position in Haemonetics in Q2 2013 and has held it in 52 quarters since.
Israel Englander's Haemonetics position peaked at $86.6M in Q1 2018.
327 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.